Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia

Enrolling by invitationOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

January 30, 2023

Study Completion Date

December 31, 2024

Conditions

Cervical Dystonia

Interventions

DEVICE

DBS-device, implanted in GPi bilaterally

Chronic/continuous bilateral GPi-DBS

DRUG

Botulinum toxin

Repeated intramuscular injections at regular intervals of around 3 months

Trial Locations (1)

Oslo University Hospital, Oslo

All Listed Sponsors

lead

Oslo University Hospital

OTHER